403 related articles for article (PubMed ID: 28633765)
1. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.
Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869
[TBL] [Abstract][Full Text] [Related]
4. Planned neck dissection before combined chemoradiation in organ preservation protocol for N2-N3 of supraglottic or hypopharyngeal carcinoma.
Liu XK; Li Q; Zhang Q; Su Y; Shi YX; Li H; Zeng ZY; Guo ZM
ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):64-9. PubMed ID: 22327028
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
[TBL] [Abstract][Full Text] [Related]
6. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.
Zhou MJ; van Zante A; Lazar AA; Groppo ER; Garsa AA; Ryan WR; El-Sayed IH; Eisele DW; Yom SS
Head Neck; 2018 May; 40(5):904-916. PubMed ID: 29210145
[TBL] [Abstract][Full Text] [Related]
8. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
[TBL] [Abstract][Full Text] [Related]
9. Cancer of unknown primary: does treatment modality make a difference?
Balaker AE; Abemayor E; Elashoff D; St John MA
Laryngoscope; 2012 Jun; 122(6):1279-82. PubMed ID: 22538837
[TBL] [Abstract][Full Text] [Related]
10. Unknown primary squamous cell carcinoma of the head and neck: retrospective analysis of 80 cases.
Mizuta M; Kitamura M; Tateya I; Tamaki H; Tanaka S; Asato R; Shinohara S; Takebayashi S; Maetani T; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Ichimaru K; Honda K; Yamada K; Omori K
Acta Otolaryngol; 2018 Jun; 138(6):590-596. PubMed ID: 29310489
[TBL] [Abstract][Full Text] [Related]
11. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
[TBL] [Abstract][Full Text] [Related]
12. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
13. Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary.
Dequanter D; Lothaire P; Gastelblum P; Nguyen TH; Lalami Y; Awada A; Andry G
B-ENT; 2008; 4(3):157-61. PubMed ID: 18949962
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
[TBL] [Abstract][Full Text] [Related]
15. Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.
Fakhrian K; Thamm R; Knapp S; Molls M; Pigorsch S; Haller B; Geinitz H
Strahlenther Onkol; 2012 Jan; 188(1):56-61. PubMed ID: 22189437
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
[TBL] [Abstract][Full Text] [Related]
17. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of bilateral neck metastases in laryngeal cancer].
Fujii T; Sato T; Yoshino K; Inakami K; Hashimoto M; Uemura H; Nagahara M; Umatani K
Nihon Jibiinkoka Gakkai Kaiho; 1996 May; 99(5):661-8. PubMed ID: 8691303
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.
Boscolo-Rizzo P; Gava A; Da Mosto MC
Ann Surg Oncol; 2007 May; 14(5):1575-82. PubMed ID: 17508250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
